TCRT Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Market Insider TCRT
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Institutional Ownership
About 12.08% of TCRT shares are held by financial institutions. EVERSOURCE WEALTH ADVISORS, LLC is the top corporate investor, holding 40 shares valued at $3.00. A 0% stake in Alaunos Therapeutics, Inc. is owned by the company. VANGUARD GROUP INC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
TCRT Insiders
Among the TCRT insiders holding of 14.3% of the stake in company, POSTMA ROBERT W, director, holds the largest shares of 5M. COOPER LAURENCE JAMES NEIL, President and CEO, is the second largest TCRT insider with ownership of 1.8M shares. BOYLE KEVIN S. SR., Chief Executive Officer, stands third with possession of 798.24K shares of that stake.
Buying/Selling by Insiders
Insider Transaction Summary (6 Months)
Frequently Asked Questions
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TCRT shares is 33, representing 12.08% of the company's common stock.
VANGUARD GROUP INC, in the last quarter, reduced its stake in TCRT by -100% restricting it's holding to 0 shares of worth nearly -. GOLDMAN SACHS GROUP INC also lessened -100% of the TCRT shares from its portfolio, reducing its holding to 0 shares of worth -. COMMERCE BANK also shunned TCRT shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, GEODE CAPITAL MANAGEMENT, LLC increased its stake in TCRT by 4.29% in the last quarter. The institutional holder raised its holding to 2.26 million shares having worth more than $159.56K. SQUAREPOINT OPS LLC also added 100% more shares of TCRT to its portfolio, raising its holding to 446.26 thousand shares of worth $31.55K. RENAISSANCE TECHNOLOGIES LLC also increased its TCRT shares holding by 100% which brought its holding to 382 thousand shares worth $27.00K.
The insider with the most stakes in TCRT is Postma Robert W , director at the company. Additionally, TCRT stock is highly held by President and CEO Cooper Laurence James Neil and Chief Executive Officer Boyle Kevin S. Sr. among others.
Company executives, directors, and other insiders own 14.3% percent of Alaunos Therapeutics, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which TCRT insiders have sold stock, totaling 818 shares. Insiders that have sold shares include VIESER JAIME, BOYLE KEVIN S. SR., and DE GROOT ELEANOR.
There have been 0 transaction(s) during the past 6-months in which Alaunos Therapeutics, Inc. insiders have bought stock, totalling 0 shares
Around 25.89K Alaunos Therapeutics, Inc. shares are held by insiders, which represents about 14.3% of TCRT stock.
TCRT director, Postma Robert W holds the largest portfolio of the company's shares. TCRT shares owned by Postma total nearly 5 million.
EVERSOURCE WEALTH ADVISORS, LLC is the largest institutional owner in TCRT which holds 40 shares worth $3.00 or 0% of the total TCRT shares outstanding followed by VANGUARD GROUP INC with ownership of 0 shares representing 0% of the TCRT ownership. GOLDMAN SACHS GROUP INC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TCRT is concerned, it is a stock which is not optionable.
Number of TCRT shares short is 139.31K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 1.60M shares of TCRT are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TCRT has 1.31M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TCRT is 10.12.